Pemetrexed (Pem) with pembrolizumab (Pembro) maintenance: A post hoc subgroup safety analysis of KEYNOTE-189.

Joachim Aerts,Edward B. Garon,Chunxiao Wang,Catherine Muehlenbein,Jong Seok Kim,Shirish M. Gadgeel

Pemetrexed (Pem) with pembrolizumab (Pembro) maintenance: A post hoc subgroup safety analysis of KEYNOTE-189.

2020

Joachim Aerts
Edward B. Garon
Chunxiao Wang
Catherine Muehlenbein
Jong Seok Kim
Shirish M. Gadgeel

51Background: KEYNOTE-189 showed that Pembro+Pem and platinum (Plat) followed by Pembro+Pem improved survival vs Placebo(Plac)+Pem+Plat followed by Plac+Pem in nonsquamous metastatic non-small cell...

Keywords:

post hoc
Pemetrexed
Pembrolizumab
Internal medicine
Medicine
Placebo
Oncology
Pathology
improved survival

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations